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Abstract
Objective
To determine the contribution of electrophysiologic testing in the diagnosis and anatomical
classiﬁcation of myoclonus.
Methods
Participants with a clinical diagnosis of myoclonus were prospectively recruited, each un-
dergoing a videotaped clinical examination and battery of electrophysiologic tests. The di-
agnosis of myoclonus and its subtype was reviewed after 6 months in the context of the
electrophysiologic ﬁndings and specialist review of the videotaped clinical examination.
Results
Seventy-two patients with myoclonus were recruited. Initial clinical anatomical classiﬁcation
included 25 patients with cortical myoclonus, 7 with subcortical myoclonus, 2 with spinal
myoclonus, and 15 with functional myoclonic jerks. In 23 cases, clinical anatomical classiﬁca-
tion was not possible because of the complexity of the movement disorder. Electrophysiologic
testing was completed in 66, with agreement of myoclonus in 60 (91%) and its subtype in 28
(47%) cases. Subsequent clinical review by a movement disorder specialist agreed with the
electrophysiologic ﬁndings in 52 of 60; in the remaining 8, electrophysiologic testing was
inconclusive.
Conclusions
Electrophysiologic testing is an important additional tool in the diagnosis and anatomical
classiﬁcation of myoclonus, also aiding in decision-making regarding therapeutic management.
Further development of testing criteria is necessary to optimize its use in clinical practice.
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Myoclonus is a frequently observed hyperkinetic movement
disorder, which is often classiﬁed according to its anatomical
origin: cortical myoclonus (CM), subcortical myoclonus
(SCM), spinal myoclonus (SM), peripheral myoclonus
(PM), or functional jerks (FJ) in case of a functional move-
ment disorder.
Electrophysiologic testing is frequently useful in distinguishing
myoclonus from other hyperkineticmovement disorders, and in
identifying its anatomical origin.1–3 The tests used in the as-
sessment of myoclonus include polymyography, EEG-EMG
back-averaging, coherence analysis, and somatosensory evoked
potential (SSEP).4–8 Table 1 summarizes the electrophysiologic
criteria used in the diagnosis of myoclonus and its subtypes.
The sensitivity and speciﬁcity of electrophysiologic testing in
patients with myoclonus are largely unknown, with the ma-
jority of work to date being limited by small cohorts, highly
selected patient populations, or reliance on expert opinion to
determine the diagnosis.9–11
Our recent retrospective analysis of 85 patients with myoclonus
demonstrated the key clinical and electrophysiologic features in
distinguishingmyoclonus subtypes.12 In 74% of cases, the clinical
diagnosis of myoclonus was conﬁrmed with electrophysiologic
testing, and electrophysiologic assessment of the myoclonus
subtype aided diagnosis in 73% of cases. In this study, we sought
to apply these principles to a prospectively recruited cohort of
patients, evaluating the contribution of electrophysiologic testing
in the diagnosis and management of myoclonus.
Methods
Participants
Participants with a clinical diagnosis of myoclonus were
identiﬁed prospectively from inpatient and outpatient settings
(July 2014 to June 2016). Exclusion criteria included ongoing
inpatient care on the intensive care unit, language and/or
literacy barriers, and age 6 years or younger. All participants
were followed up for a minimum of 6 months, after which
a ﬁnal diagnosis was made.
Initial clinical classification
The initial clinical diagnosis of myoclonus and its anatomical
subtype was provided by the participants’ primary caring neu-
rologist (adult or pediatric), with all participants undergoing
a standardized and systematic assessment, including videotaped
clinical examination.
Electrophysiologic testing
The standardized electrophysiologic protocol included an
initial polymyography, with participants excluded at this stage
if the myoclonus was too subtle to adequately perform the
assessment. For those meeting electrophysiologic criteria for
myoclonus, further investigations included EEG-EMG back-
averaging (if >25 jerks) or coherence analysis (if jerk fre-
quency was >3Hz).Where possible, those with CM and SCM
underwent testing for SSEPs (ﬁgure e-1, http://links.lww.
com/WNL/A164).
An experienced neurophysiologist (J.W.E. and J.H.v.d.H.)
blinded to the original clinical diagnosis determined whether
the ﬁndings were consistent with myoclonus, and the likely
myoclonus subtype. Table 1 summarizes the electrophysio-
logic criteria used in determining diagnosis.12
Diagnostic review and 6-month follow-up
Aneurologist with expertise inmovement disorders (M.A.J.T.),
blinded to the initial diagnoses, reviewed the clinical details,
videotaped clinical examination, and results of the electro-
physiologic testing. Each patient was reviewed again 6 months
after their initial assessment to determine any changes to the
clinical ﬁndings, with the ﬁnal diagnosis being conﬁrmed by the
specialist (ﬁgure 1).
Severity of the myoclonus
The severity of the myoclonus was determined by 2 in-
dependent clinicians (R.Z. and J.C.v.Z. or J.M.G.) following
review of the videotaped clinical examinations, scoring sec-
tions 2 and 4 of the UniﬁedMyoclonus Rating Scale (UMRS),
and the 7-point Global Clinical Impression–Severity (GCI-S)
scale.
Power analysis
A power calculation was performed based on our previously
reported retrospective analysis.12 It was estimated that elec-
trophysiologic testing would support the clinical diagnosis of
the myoclonus anatomical subtype in approximately 70%. A
change in clinical classiﬁcation of >20%, due to electrophys-
iologic testing, was considered clinically relevant. Using the
One Proportion Conﬁdence Interval Formula: Exact
(Clopper-Pearson), a 95% conﬁdence level, 0.7 (proportion),
0.8 (upper limit), we estimated that a minimum of 56 par-
ticipants would need to be recruited.
Statistical analysis
The clinical characteristics were analyzed using Kruskal-
Wallis tests for continuous, nonnormally distributed data.
Glossary
CHAID = Chi-squared Automatic Interaction Detection; CM = cortical myoclonus; CS = cortical spike; FJ = functional jerks;
GCI-S = Global Clinical Impression–Severity; ICC = intraclass correlation coeﬃcient; MMS = multiple myoclonus subtype;
PM = peripheral myoclonus; SCM = subcortical myoclonus; SM = spinal myoclonus; SSEP = somatosensory evoked potential;
UMRS = Uniﬁed Myoclonus Rating Scale.
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Table 1 Electrophysiologic criteria of myoclonus and to aid diagnosis by anatomical subtype12
Myoclonus/anatomical subtype Video-polymyography
Back-averaging/coherence
analysis/SSEP
Importance of
criterion
Myoclonus Abrupt muscle contraction or
interruption of muscle activity
Required
Synchronous contraction of agonist
and antagonist muscles8,19
Supportive
Cortical myoclonus Burst duration positive myoclonus
<100 ms
Required
Multifocal/focal distribution Supportive
Presence of negative myoclonus8 Supportive
Positive cortical spike back-averaging:
Presence of a “time locked” biphasic
potential >2 SD above baseline on the
contralateral motor cortex preceding
the jerks seen on the EMG according
to the conduction time of
corticospinal pathways (arms 15–25
ms/legs ±40 ms)8,20
Diagnostic
Positive corticomuscular coherence:
Occurrence of significant
corticomuscular coherence in the
alpha and beta band with a phase
difference consistent with a cortical
generator6,7,21
Diagnostic
Presence of a giant SSEP: The P27 and
N35 peaks had large amplitudes >5
μV and had a suitable shape20,22,23
Diagnostic
Subcortical myoclonus
Brainstem Burst duration >100 ms Supportive
Simultaneous rostral and caudal
muscle activation at brainstem
level24,25
Required
M-D/other Burst duration >100 ms Supportive
Presence of negative myoclonus Supportive
Do not meet criteria of other
categories26
Required
Spinal myoclonus
Segmental Burst duration >100 ms Supportive
Distribution according to 1 or 2
contiguous spinal segments
Required
Rhythmic (1–2/min to 240/min) Supportive
Propriospinal Burst duration >100 ms20
Initiation in mid thoracic segments
followed by rostral and caudal
activation27,28
Required
Propagation with slow velocity (5–15
m/s) in cord20
Required
Peripheral myoclonus Burst duration <50 ms Required
Large MUAPs Supportive
Minipolymyoclonus or fasciculations/
myokymia
Supportive
Accompanied by weakness/atrophy29 Supportive
Continued
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Interrater reliability was assessed using the intraclass corre-
lation coeﬃcient (ICC) (2-way mixed, consistency, average
measures),13 or Cohen κ14 where appropriate. A Chi-squared
Automatic Interaction Detection (CHAID) (SPSS, IBM,
Armonk, NY; parent nodes n < 3, child nodes n > 1) analysis
was undertaken to generate a decision tree in order to quantify
the importance of the clinical and electrophysiologic criteria
in the diagnosis of the myoclonic subtypes.
Standard protocol approvals, registrations,
and patient consents
Full written informed consent was obtained from all participants
according to the Declaration of Helsinki. The study protocol
was approved by the University Medical Centre Groningen
ethics committee (M14.157933, approved July 2, 2014).
Results
Overall cohort
A total of 72 patients (32 male; 40 female) were recruited,
with a median age of 29 years (range: 7–83 years), 59 from the
outpatient setting and 13 from inpatient care.
The demographic details and clinical characteristics of this
cohort are summarized in table 2 and table e-1 (http://links.
lww.com/WNL/A165), respectively.
Table 1 Electrophysiologic criteria of myoclonus and to aid diagnosis by anatomical subtype12 (continued)
Myoclonus/anatomical subtype Video-polymyography
Back-averaging/coherence
analysis/SSEP
Importance of
criterion
Functional jerks Variable muscle recruitment Supportive
Variable burst duration (>100 ms) Supportive
Distractibility and/or entrainment1,30 Supportive
Presence of a Bereitschaftspotential:
Presence of a clear slow negative
electrical shift (>5 μV) over the central
cortical areas that increased over
time 1–2 s beforemovement onset5,31
Diagnostic
Abbreviations: M-D = myoclonus dystonia; MUAP = motor unit action potential; SSEP = somatosensory evoked potential.
Figure 1 Overview of the stages of clinical assessment and diagnosis undertaken in this study
CM= corticalmyoclonus; FJ = functional jerks;MD=movement disorder;MMS =multiplemyoclonus subtypes; SCM= subcorticalmyoclonus; SM= spinalmyoclonus.
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Table 2 Demographic features of the myoclonus cohort
Demographic features CM (n = 33) SCM (n = 4) FJ (n = 20) MMS (n = 3) Total (n = 60)
Sex, M/F 15/18 2/2 7/13 1/2 25/35
Age at examination, ya 21 (7–83) 18.5 (15–48) 31.5 (16–73) 63 (18–73) 22 (7–83)
Age at onset of myoclonus, ya 14 (0–83) 11 (10–14) 25 (12–66) 60 (4–73) 18 (0–83)
Follow-up interval, mob 21 22 22 15 20
UMRSa
Rest 9 (0–38) 14 (9–23) 17 (2–30) 9 (6–18) 11 (0–38)
Action 19 (6–57) 15 (7–23) 8 (0–33) 16 (0–31) 15 (0–57)
Total 31 (7–85) 31 (19–42) 23 (5–62) 28 (6–49) 27 (5–85)
GCI-Sa 3 (2–7) 4 (3–5) 4 (2–6) 4 (3–5) 4 (2–7)
Family history of a related disorder 7 3 2 1 13
Other neurologic symptoms
Eye movement disorder 8 0 0 0 8
Dystonia 9 4 0 1 14
Chorea 3 0 0 0 3
Ataxia 4 0 0 0 4
Comorbidity
Psychiatric 5 0 4 0 9
Epilepsy 9 0 0 0 9
Cognitive problems 7 2 0 0 9
Liver or kidney disease 5 0 2 0 7
Structural damage to brain 3 0 1 0 4
Treatment
No treatment 14 3 5 1 23
Clonazepam 9 (4) 0 0 2 (2) 11 (6)
Levetiracetam 9 (6) 0 0 0 9 (6)
Valproic acid 3 (1) 1 (0) 0 1 (0) 5 (1)
Multiple drug therapy 5 (4) 0 0 0 5 (4)
Physiotherapy 0 0 10 (5) 1 (1) 11 (6)
Explanation diagnosis 0 (0) 0 (0) 5 (5) 0 (0) 5 (5)
Side effects, yes/no
Clonazepam 5/4 0/0 0/0 0/2 5/6
Levetiracetam 7/2 0/0 0/0 0/0 7/2
Valproic acid 3/0 0/1 0/0 0/1 3/2
Multiple drug therapy 3/2 0/0 0/0 0/0 3/2
Abbreviations: CM = cortical myoclonus; FJ = functional jerks; GCI-S = Global Clinical Impression–Severity; MMS = multiple myoclonus subtypes; SCM =
subcortical myoclonus; UMRS = Unified Myoclonus Rating Scale.
Classification ofmyoclonus is given as the final diagnosis following review at 6months post diagnosis. Treatment: the number in parentheses is the number of
patients in whom the myoclonus improved with treatment.
a Values are displayed as median (range).
b Values are displayed as mean.
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Clinical diagnosis of myoclonus pre-
electrophysiologic testing
Of the 72 individuals with myoclonus, these were subdivided
into CM (n = 25), SCM (n = 7), SM (n = 2), and FJ (n = 15),
with subtype diagnoses not possible in 23 patients (32%)
because of the complexity of the movement disorder.
Electrophysiologic diagnoses
In 6 patients (8%), clinically diagnosed with distal multifocal
CM, the myoclonic jerks were of such small amplitude that the
polymyographic recordings were indeterminate and unable to
be interpreted. Of the remaining 66 patients, electrophysiologic
testing supported a diagnosis of myoclonus in 60 (91%), with
these subdivided into CM (n = 30), SCM (n = 10), multiple
myoclonus subtypes (MMS) (n = 3), and FJ (n = 17). A
cortical origin was detected in 5 of 9 patients (60%) with CM
using back-averaging, and 16 of 20 (80%) using coherence
analysis. SSEP analysis demonstrated giant potentials in 3 of 14
patients (21%) with CM, and a Bereitschaftspotential was
identiﬁed in 5 of 12 patients (42%) with FJ.
A full summary of the electrophysiologic characteristics of this
cohort can be seen in table 3.
Comparison of clinical and
electrophysiologic diagnoses
There was agreement between the clinical diagnosis and
electrophysiologic testing in a diagnosis of myoclonus for 91%
(60/66) of the study cohort. Of these 60 cases, there was
agreement of its subtype in 28 cases (47%) (14 CM, 2 SCM,
and 12 FJ) and disagreement in 15 cases (25%). Of the
remaining 17 cases (28%) without a clinical subclassiﬁcation,
electrophysiologic testing proved helpful, subdividing these
into 12 CM, 2 SCM, and 3 FJ (table e-2, http://links.lww.
com/WNL/A165).
Clinical opinion of the movement
disorder specialist
There was agreement between the electrophysiologic testing
and specialist movement disorder opinion in 66 cases, and
agreement on its subtype in 52 of 60 cases (87%), considered
a “substantial” agreement (κ = 0.78). A summary of the 8 cases
in which there was disagreement between expert clinical di-
agnosis and electrophysiologic testing is provided in table 4;
in each, there was a lack of conclusive electrophysiologic
ﬁndings to facilitate a diagnosis of myoclonus subtype.
Final clinical diagnoses
Follow-up review after 6 months resulted in no changes to
clinical diagnosis in all 60 patients, with the ﬁnal sub-
classiﬁcation including 33 CM (55%), 4 SCM (7%), 3 MMS
(5%), and 20 FJ (33%). The CHAID analysis demonstrated
(1) polymyographic measurement of the myoclonic burst
duration, (2) exacerbation of the myoclonus with action, and
(3) facial involvement to be the most important criteria in
determining myoclonic subtype (ﬁgure e-2, http://links.lww.
com/WNL/A164).
Severity of myoclonus
The median UMRS severity score was 27 (Rest 11/128, Ac-
tion 15/144) and GCI-S score 4/7. No signiﬁcant statistical
diﬀerence was observed between the subtypes of myoclonus
(p = 0.2). The interrater concordance was “excellent” (ICC =
0.94 [95% conﬁdence interval: 0.9–0.96]) and “good” (ICC =
0.72 [95% conﬁdence interval: 0.58–0.82]) for the UMRS
and GCI-S, respectively.
Underlying etiology of the myoclonus
Of the 40 patients diagnosed with an organic movement
disorder, an underlying etiology was identiﬁed in 21 patients
(53%). In 12 patients, a causative genetic mutation was
identiﬁed, and 9 were found to have an acquired cause in-
cluding metabolic disturbances (n = 3), drug-induced myoc-
lonus (n = 1), and structural brain lesions (n = 2). Of those
with an underlying genetic etiology, the highest rate was
among those with CM (n = 10), with mutations in the
NKX2.1 (n = 2) and NPC1 (n = 2) genes being most com-
mon. A single case of a contiguous gene deletion (578 kb,
16p11.2) involving the PRRT2 gene was identiﬁed with an
extended phenotype including psychomotor retardation,
hemiplegic migraine, epilepsy, myoclonus, and dystonia. All
patients with a myoclonic epilepsy syndrome had evidence of
epileptiform discharges on EEG, with the CM in those with
juvenile myoclonic epilepsy and Lafora disease demonstrating
an epileptic origin. All 4 patients with SCM had a clinical
diagnosis of myoclonus dystonia, with a RELN variant iden-
tiﬁed in one patient. Table 5 summarizes the etiologic di-
agnoses and additional clinical characteristics.
Discussion
This prospective study has sought to demonstrate the beneﬁt
of electrophysiologic testing alongside clinical examination, in
determining the diagnosis of myoclonus and its subtype in an
unselected cohort. We have shown that this combined ap-
proach leads to changes in the initial diagnosis of myoclonus
and its subtype in 53% of cases.
Overall, agreement of a diagnosis of myoclonus between the
examining clinicians and the electrophysiologic ﬁndings was
91% (n = 60), decreasing to 47% (n = 28) with anatomical
subtype. These ﬁndings contrast with results from similar
studies in tremor cohorts (n = 210) where agreement between
the 2 assessment forms was 87%, potentially reﬂecting greater
clinical familiarity and larger patient cohorts.15–17 We identiﬁed
several clinical groups in which there was some consistency in
the change in diagnosis following electrophysiologic testing.
These included those with multifocal myoclonus (principally
distinguishing between CM and SCM), combined movement
disorders (e.g., myoclonus in the presence of dystonia), and
functional jerks. The ﬁndings from this study also reﬂect the
diﬃculty in determining a conclusive clinical diagnosis with
myoclonus, and lend weight to the importance of electro-
physiologic testing, particularly in nonspecialist centers.
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Higher-level electrophysiologic techniques were used to de-
termine whether the myoclonus was of cortical origin or an FJ.
The yield of back-averaging and coherence analysis to conﬁrm
a cortical origin was 60% and 80%, respectively. The additive
value of these techniques was lower than the 100% seen in
previous studies, potentially attributable to the heterogeneity
Table 3 Electrophysiologic characteristics of each subtype based on the electrophysiologic findings
Electrophysiologic characteristics CM SCM FJ MMS Total
No. 30 10 17 3 60
Type
Positive 15 8 17 2 42
Negative 0 1 0 0 1
Both 15 1 0 1 17
Burst duration, ms
30–50 2 0 0 1 3
50–100 27 2 0 1 30
50–200 0 5 1 1 7
100–300 0 1 3 0 4
>300 0 0 2 0 2
Variable 1 2 11 0 14
Distribution
Focal 1 1 0 1 3
Multifocal 29 9 7 1 46
Segmental 0 0 0 1 1
Generalized 0 0 0 0 0
Variable 0 0 10 0 10
Back-averaging
CS present 5 0 0 2 7
BP present 0 0 5 0 5
CS absent 4 3 0 0 7
BP absent 0 1 7 0 8
Not performed 15 1 0 1 17
Not possible 6 5 5 0 16
Positive coherence
Present (segment sec) 16 0 0 0 16
Absent (segment sec) 4 4 0 1 9
Not performed 10 6 17 2 35
Giant SSEP
Present 3 0 0 0 3
Absent 11 5 1 2 19
Not performed 13 5 15 1 34
Unable to interpret 3 0 1 0 4
Abbreviations: BP = Bereitschaftspotential; CM = cortical myoclonus; CS = cortical spike; FJ = functional jerks; MMS = multiple myoclonus subtype; SCM =
subcortical myoclonus; SSEP = somatosensory evoked potential.
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Table 4 Details of cases in which the clinical diagnosis changed after evaluation by the movement disorders specialist
No.
Age at
onset, ya
Age at
examination, ya Clinical features
Electrophysiologic
findings
Electrophysiologic
diagnosis
Expert clinical
diagnosis
Final clinical
diagnosis
Reasons for revising the
electrophysiologic diagnosis
1 10 20 Distal limbs and face 50–200 ms SCM CM CM Distal distribution
Provocation by action Back-averaging NP Facial involvement
Stimulus sensitive Stimulus sensitivity
No firm electrophysiologic results
2 0 10 Distal > proximal limbs Positive and negative SCM CM CM Distal distribution
Face 50–100 ms Facial involvement
Provocation by action Back-averaging NP Stimulus sensitivity
Stimulus sensitive No firm electrophysiologic results
3 69 69 Negative myoclonus Negative SCM CM CM Negative myoclonus
Distal limbs 50–100 ms Metabolic derangements
Provocation by action Back-averaging NP No firm electrophysiologic results
Metabolic
derangements
4 6 7 Distal limbs 50–200 ms SCM CM CM Distal distribution
Provocation by action Negative back-
averaging
Stimulus sensitivity
Stimulus sensitive Co-occurrence of epilepsy
Epilepsy No firm electrophysiologic results
5 16 17 Acute onset 50–200 ms SCM FJ FJ Acute onset
Distal upper limbs Negative back-
averaging
Atypical sensory problems
Entrainment Entrainment
Atypical sensory
problems
No firm electrophysiologic results
6 18 18 Acute onset Variable duration SCM FJ FJ Acute onset
Distal limbs Multifocal Stimulus sensitive
Continued
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Table 4 Details of cases in which the clinical diagnosis changed after evaluation by the movement disorders specialist (continued)
No.
Age at
onset, ya
Age at
examination, ya Clinical features
Electrophysiologic
findings
Electrophysiologic
diagnosis
Expert clinical
diagnosis
Final clinical
diagnosis
Reasons for revising the
electrophysiologic diagnosis
Stimulus sensitive Back-averaging NP Change with distraction
Change with
distraction
No firm electrophysiologic results
7 20 20 Subacute onset 50–200 ms SCM FJ FJ Provocation by rest
Proximal and distal Negative back-
averaging
Stimulus sensitive
Provocation by rest Change with distraction
Stimulus sensitive No firm electrophysiologic results
Change with
distraction
8 14 20 Myoclonus, dystonia,
tremor
Positive and negative CM SCM SCM Combined myoclonus and dystonia
Cognitive difficulties 50–100 ms No firm electrophysiologic results
Proximal and distal Back-averaging NP
Abbreviations: CM = cortical myoclonus; FJ = functional jerks; NP = not performed; SCM = subcortical myoclonus.
a Values are displayed as median.
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of our cohort in contrast to smaller, more selected study
groups (n = 20/n = 3).9,18 A CHAID analysis demonstrated
that a combination of polymyography (burst duration) and
clinical phenomenology provided the greatest accuracy (95%)
in determining myoclonus subtype.
This study is limited by the lack of a deﬁnitive diagnostic test or
marker. We have sought to reduce this by ensuring a minimum
6-month follow-up period to allow for any changes in clinical
symptomatology. However, this lack of objective testing also
serves to reinforce the potential gain of routine electrophysi-
ologic testing to both aid, and provide additional evidence of
the diagnosis of myoclonus and its subtype. Our cohort also
likely reﬂects a more complex group of patients than might be
expected in routine clinical practice, because of recruitment
from a single specialist movement disorder center. We also
acknowledge that while the electrophysiologic tests discussed
are readily available within our center, such access varies con-
siderably between centers and internationally.
Electrophysiologic testing is an important contributing di-
agnostic tool for the classiﬁcation of myoclonus and its sub-
types. While this clearly constitutes an important element of
clinical work for neurologists with an interest in movement
disorders, this algorithm of testing is also likely to be of use for
those working in the ﬁelds of metabolic disorders, pediatrics,
and epilepsy. Further development of the electrophysiologic
criteria for myoclonus subtypes, and application of this work
to larger, unselected patient cohorts is essential to improve its
objectivity and diagnostic value.
Table 5 Underlying etiologic diagnoses and additional clinical characteristics
Myoclonus
subtype Etiologic diagnosis or syndrome Additional clinical characteristics No.
CM (n= 33) Juvenile Huntington (CAG repeat in HTT gene) Cognitive impairment, severe epilepsy, spasticity 1
Wilson disease (mutation ATP7B gene) Parkinsonism, dystonia, ataxia, cognitive impairment 1
Niemann-Pick type C (NPC1 mutation) Eye movement disorder, ataxia, dystonia (n = 1) 2
Lafora disease (mutation NHLRC1 gene) Severe epilepsy, mild cognitive impairment 1
Juvenile myoclonus epilepsy (no genetic mutation identified) Epilepsy 1
Myoclonus epilepsy (no genetic mutation identified) Epilepsy, mild cognitive impairment 1
Ramsay Hunt syndrome (GOSR mutation) Ataxia, areflexia, eye movement disorder 1
Ramsay Hunt syndrome (no genetic mutation identified) Ataxia, areflexia, eye movement disorder 1
Benign hereditary chorea (mutation NKX2.1 gene) Chorea, dystonia, areflexia 2
Paroxysmal kinesigenic dyskinesia (16p11.2 deletion [578 kb],
including the PRRT2 gene)
Severe cognitive impairment, hemiplegic migraine,
epilepsy, dystonia
1
Myoclonus dystonia (18p11.21 deletion [14.9 Mb]) Dystonia 1
Myoclonus dystonia (no genetic mutation identified) Dystonia, bradykinesia (n = 1), eye movement disorder
(n = 1)
2
Medication-induced Cognitive impairment (n = 1) 2
Metabolic derangements due to liver or kidney disease Cognitive impairment (n = 2), polyneuropathy (n = 1) 3
Structural cerebral lesion Mild cognitive impairment (n = 1), vascular
parkinsonism (n = 1)
2
Unknown 11
SCM (n = 4) Myoclonus dystonia (RELN variant) Dystonia 1
Myoclonus dystonia (no genetic mutation identified) Dystonia 3
Unknown 0
MMS (n = 3) Myoclonus dystonia (RELN variant) Dystonia 1
Creutzfeldt-Jakob disease Cognitive impairment, stiffness 1
Lumbar radiculopathy and FJ Functional gait problem 1
Unknown 0
Abbreviations: CM = cortical myoclonus; FJ = functional jerks; MMS = multiple myoclonus subtypes; SCM = subcortical myoclonus.
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